ARCHIVES

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

This article is from The Cancer Letter archive.

Vol. 13 No. 36 | September 18, 1987

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion.

February 8, 2008

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Two Drugs Combined Better Than One Alone, Study Finds

February 27, 2009

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

January 3, 1992

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993